Related Experiment Video
Updated: Aug 18, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
[New lipid factors of cardiovascular risk]
1Service d'Endocrino-métabolisme, Hôpital de la Pitié, Paris.
Insights
Individualized hyperlipidemia management requires assessing cardiovascular risk factors, including patient characteristics, lipid profiles, and atherosclerosis. Precise risk assessment aids in selecting appropriate treatment goals for better patient outcomes.
Area of Science:
- Cardiology
- Metabolic Disorders
- Preventive Medicine
Context:
- Hyperlipidemia necessitates personalized treatment strategies.
- Cardiovascular risk assessment is crucial for managing hyperlipidemia.
- Evaluation includes immutable characteristics, traditional risk factors, and atherosclerosis.
Purpose:
- To outline a comprehensive approach for evaluating cardiovascular risk in hyperlipidemia patients.
- To illustrate precise lipid risk assessment using specific clinical examples.
- To guide treatment goal selection based on individual risk profiles.
Summary:
- Patient management for hyperlipidemia is individualized based on cardiovascular risk evaluation.
- Risk assessment incorporates unchangeable factors (age, gender), lipid/non-lipid factors, and atherosclerosis.
- Syndrome X, familial hyperlipidemia, and lipoprotein (a) serve as examples for precise risk stratification.
Impact:
- Enables more accurate patient risk stratification for hyperlipidemia.
- Facilitates tailored treatment decisions and goal setting.
- Improves the management of cardiovascular risk associated with hyperlipidemia.
Abstract:
Each hyperlipidemia patient requires individual management. Treatment choices are thus made for each patient on the basis of evaluation of their overall cardiovascular risk. This evaluation involves four types of characteristics: those which cannot be changed (age, gender), classical lipid and non-lipid risk factors, and finally cardiovascular status with two types of evaluation (clinical status and sub-clinical, atherosclerosis). Three examples are presented here, enabling more precise assessment of lipid risk: syndrome X which shows to what extent risk factors are often associated, combined familial hyperlipidemia which emphasises the importance of family history, and lipoprotein (a). The latter is a risk factor relatively inaccessible to treatment but which enables better evaluation of the risk of the patient and choice of a stricter treatment goal when it is very high.
Related Concept Videos
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management

